Twist Bioscience Corporation
NASDAQ:TWST
47.99 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 286.47 | 378.687 | 465.829 | 93.667 | 46.735 | 80.757 | 31.227 | 28.596 |
| Short Term Investments
| 49.943 | 126.281 | 12.034 | 196.335 | 91.372 | 0 | 30.977 | 27.324 |
| Cash and Short Term Investments
| 336.413 | 504.968 | 477.863 | 290.002 | 138.107 | 80.757 | 62.204 | 55.92 |
| Net Receivables
| 44.064 | 40.294 | 28.549 | 26.376 | 12.104 | 5.419 | 2.346 | 0.723 |
| Inventory
| 32.063 | 39.307 | 31.8 | 12.289 | 7.33 | 6.028 | 1.827 | 1.228 |
| Other Current Assets
| 11.716 | 11.914 | 8.283 | 6.203 | 2.594 | 3.467 | 1.492 | 1.168 |
| Total Current Assets
| 424.256 | 596.483 | 546.495 | 334.87 | 160.135 | 95.671 | 67.869 | 59.039 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 203.361 | 214.389 | 105.702 | 59.165 | 20.835 | 12.331 | 14.834 | 14.617 |
| Goodwill
| 85.811 | 85.811 | 22.434 | 1.138 | 1.138 | 1.138 | 1.138 | 1.138 |
| Intangible Assets
| 54.483 | 59.738 | 18.262 | 0.307 | 0.508 | 0.712 | 0.92 | 1.133 |
| Goodwill and Intangible Assets
| 140.294 | 145.549 | 40.696 | 1.445 | 1.646 | 1.85 | 2.058 | 2.271 |
| Long Term Investments
| 2.811 | 1.572 | 1.53 | 0.579 | 0.579 | 0.579 | 0.202 | 0.322 |
| Tax Assets
| -2.811 | -1.572 | -1.53 | -0.579 | -0.579 | -0.579 | -0.202 | -0.322 |
| Other Non-Current Assets
| 8.492 | 4.957 | 9.204 | 3.402 | 4.378 | 5.939 | 0.896 | 0.536 |
| Total Non-Current Assets
| 352.147 | 364.895 | 155.602 | 64.012 | 26.859 | 20.12 | 17.788 | 17.424 |
| Total Assets
| 776.403 | 961.378 | 702.097 | 398.882 | 186.994 | 115.791 | 85.657 | 76.463 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 14.052 | 20.092 | 14.9 | 4.83 | 9.76 | 7.531 | 2.849 | 2.337 |
| Short Term Debt
| 14.896 | 13.642 | 9.765 | 9.742 | 3.333 | 2.5 | 0 | 1.367 |
| Tax Payables
| 4.374 | 3.661 | 2.44 | 0.719 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 36.572 | 3.476 | 28.764 | 18.846 | 16.444 | 7.567 | 0 | 4.621 |
| Other Current Liabilities
| 7.803 | 53.453 | 9.623 | 2.611 | 0.817 | 0.939 | 6.628 | 0.353 |
| Total Current Liabilities
| 73.323 | 90.663 | 63.052 | 36.029 | 30.354 | 18.537 | 9.477 | 8.678 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 79.173 | 81.27 | 53.156 | 26.24 | 4.4 | 7.218 | 9.154 | 9.814 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.475 | 0.06 | 5.068 | 0.351 | 0.158 | 291.458 | 200.384 | 134.582 |
| Total Non-Current Liabilities
| 79.648 | 81.33 | 58.224 | 26.591 | 4.558 | 298.676 | 209.538 | 144.396 |
| Total Liabilities
| 152.971 | 171.993 | 121.276 | 62.62 | 34.912 | 317.213 | 219.015 | 153.074 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 186.994 | 0.631 | 199.633 | 134.037 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -1,033.034 | -828.416 | -610.553 | -458.455 | -318.524 | -210.855 | -139.619 | -80.309 |
| Accumulated Other Comprehensive Income/Loss
| -0.756 | -1.843 | 0.546 | 0.087 | 0.181 | 0.087 | 0.033 | 0.009 |
| Other Total Stockholders Equity
| 1,657.222 | 1,619.644 | 1,190.828 | 794.63 | 283.431 | 8.715 | -193.405 | -130.348 |
| Total Shareholders Equity
| 623.432 | 789.385 | 580.821 | 336.262 | 152.082 | -201.422 | -133.358 | -76.611 |
| Total Equity
| 623.432 | 789.385 | 580.821 | 336.262 | 152.082 | -201.422 | -133.358 | -76.611 |
| Total Liabilities & Shareholders Equity
| 776.403 | 961.378 | 702.097 | 398.882 | 186.994 | 115.791 | 85.657 | 76.463 |